Zivo Bioscience, Inc. (ZIVOW) — 8-K/A Filings
All 8-K/A filings from Zivo Bioscience, Inc.. Browse 1 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (1)
-
Zivo Bioscience Corrects Director Fee Stock Award Date
— Jun 7, 2024 Risk: low
Zivo Bioscience, Inc. filed an amendment (8-K/A) on June 7, 2024, to correct a typographical error in a previous Form 8-K dated May 31, 2024. The correction per
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX